A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
Status:
Completed
Trial end date:
2019-08-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of INCB054707 over an 8-week treatment
period in men and women with moderate to severe hidradenitis suppurativa.